Evaluación de la satisfacción del paciente diabético con la utilización del glucómetro portátil BGSTAR© mediante el cuestionario SATIGLU

Cristóbal Morales , Guillermo Rodríguez-Munzenmaier , Dunia Marrero , José M. Baeza , Juan M. Martínez-Jiménez , Gloria Barberá , en nombre de los investigadores del estudio DIAPASAT
{"title":"Evaluación de la satisfacción del paciente diabético con la utilización del glucómetro portátil BGSTAR© mediante el cuestionario SATIGLU","authors":"Cristóbal Morales ,&nbsp;Guillermo Rodríguez-Munzenmaier ,&nbsp;Dunia Marrero ,&nbsp;José M. Baeza ,&nbsp;Juan M. Martínez-Jiménez ,&nbsp;Gloria Barberá ,&nbsp;en nombre de los investigadores del estudio DIAPASAT","doi":"10.1016/j.avdiab.2015.02.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>To assess satisfaction of patients diagnosed with Diabetes Mellitus (DM), type 1 and 2, with use of the portable glucometer BGStar<sup>©</sup> using the previously validated SATIGLU questionnaire. The relationships between satisfaction level and adherence to continuous glucose monitoring, insulin therapy, and with the level of glycemic control (% HbA1c), were also studied.</p></div><div><h3>Material and method</h3><p>Epidemiological, multicenter, cross-sectional study that included 221 diabetic patients aged over 18 years, receiving treatment with insulin and using the BGStar<sup>©</sup> glucometer. Socio-demographic and clinical data were collected, as well as treatment and adherence data. Patients self-completed the SATIGLU questionnaire and Morisky-Green (M-G). A descriptive analysis was carried out on the SATIGLU scores and other study variables. An analysis was performed to calculate the association between satisfaction scores and the number of insulin injections and the number of glucose controls (Spearman rho), and with the adherence to treatment classification according to M-G, and with the glycemic control classification according to % HbA1c. Multiple Linear Regression analysis was conducted to identify the variables associated with SATIGLU scores.</p></div><div><h3>Results</h3><p>Mean age (SD) 57.96 (15.60) years; 56.60% male; 80.82% T2DM; good glycemic control (% HbA1c≤7), 65.30%. Mean (SD) insulin injections/day, 2.35 (1.34), and blood glucose/day controls 2.56 (1.29), with 75.57% showing adherence to therapy (M-G). A positive correlation was found between the SATIGLU and the number of glycemic controls (rho<!--> <!-->=<!--> <!-->0.251; <em>P</em>=.001) and of insulin injections (rho = 0.235; <em>P</em>=.001). SATIGLU scores were higher in adherent patients and in those with better glycemic control (<em>P</em>&lt;.0001). The regression model showed that the variables associated with satisfaction were: adherence (B= 7.006; <em>P</em>&lt;.0001), and the number of glycemic controls (B= 3,214; <em>P</em>=.014).</p></div><div><h3>Conclusions</h3><p>The patients studied showed high satisfaction with the BGStar<sup>©</sup> glucometer, with a high level of adherence to insulin therapy. They also had more insulin injections, a higher number of glycemic controls, and a better DM control.</p></div>","PeriodicalId":100152,"journal":{"name":"Avances en Diabetología","volume":"31 3","pages":"Pages 120-127"},"PeriodicalIF":0.0000,"publicationDate":"2015-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.avdiab.2015.02.003","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Avances en Diabetología","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S113432301500023X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

To assess satisfaction of patients diagnosed with Diabetes Mellitus (DM), type 1 and 2, with use of the portable glucometer BGStar© using the previously validated SATIGLU questionnaire. The relationships between satisfaction level and adherence to continuous glucose monitoring, insulin therapy, and with the level of glycemic control (% HbA1c), were also studied.

Material and method

Epidemiological, multicenter, cross-sectional study that included 221 diabetic patients aged over 18 years, receiving treatment with insulin and using the BGStar© glucometer. Socio-demographic and clinical data were collected, as well as treatment and adherence data. Patients self-completed the SATIGLU questionnaire and Morisky-Green (M-G). A descriptive analysis was carried out on the SATIGLU scores and other study variables. An analysis was performed to calculate the association between satisfaction scores and the number of insulin injections and the number of glucose controls (Spearman rho), and with the adherence to treatment classification according to M-G, and with the glycemic control classification according to % HbA1c. Multiple Linear Regression analysis was conducted to identify the variables associated with SATIGLU scores.

Results

Mean age (SD) 57.96 (15.60) years; 56.60% male; 80.82% T2DM; good glycemic control (% HbA1c≤7), 65.30%. Mean (SD) insulin injections/day, 2.35 (1.34), and blood glucose/day controls 2.56 (1.29), with 75.57% showing adherence to therapy (M-G). A positive correlation was found between the SATIGLU and the number of glycemic controls (rho = 0.251; P=.001) and of insulin injections (rho = 0.235; P=.001). SATIGLU scores were higher in adherent patients and in those with better glycemic control (P<.0001). The regression model showed that the variables associated with satisfaction were: adherence (B= 7.006; P<.0001), and the number of glycemic controls (B= 3,214; P=.014).

Conclusions

The patients studied showed high satisfaction with the BGStar© glucometer, with a high level of adherence to insulin therapy. They also had more insulin injections, a higher number of glycemic controls, and a better DM control.

通过SATIGLU问卷评估使用便携式血糖仪BGSTAR©的糖尿病患者满意度
目的评估1型和2型糖尿病(DM)患者使用便携式血糖仪BGStar©的满意度,采用先前验证的SATIGLU问卷。我们还研究了满意度与坚持持续血糖监测、胰岛素治疗和血糖控制水平(% HbA1c)之间的关系。材料与方法流行病学、多中心、横断面研究,纳入221例18岁以上接受胰岛素治疗并使用BGStar©血糖仪的糖尿病患者。收集了社会人口学和临床数据,以及治疗和依从性数据。患者自行完成SATIGLU问卷和Morisky-Green (M-G)。对SATIGLU分数和其他研究变量进行描述性分析。通过分析计算满意度评分与胰岛素注射次数和血糖对照次数(Spearman rho)、与M-G治疗分级的依从性、与% HbA1c血糖控制分级的相关性。采用多元线性回归分析确定与SATIGLU评分相关的变量。结果平均年龄(SD) 57.96(15.60)岁;男性56.60%;80.82%的2型糖尿病;血糖控制良好(% HbA1c≤7),65.30%。平均(SD)胰岛素注射/天,2.35(1.34),血糖/天对照组2.56(1.29),75.57%显示治疗依从性(M-G)。SATIGLU与血糖控制次数呈正相关(rho = 0.251;P=.001)和胰岛素注射(rho = 0.235;P =措施)。坚持治疗的患者和血糖控制较好的患者的SATIGLU评分较高(P< 0.0001)。回归模型显示与满意度相关的变量为:依从性(B= 7.006;P<.0001),血糖控制人数(B= 3,214;P = .014)。结论患者对BGStar©血糖仪满意度高,胰岛素治疗依从性高。他们还接受了更多的胰岛素注射,更多的血糖控制,以及更好的糖尿病控制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信